HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret Burroughs Selected Research

Respiratory Tract Infections (Respiratory Tract Infection)

1/2020Glecaprevir-pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies- a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret Burroughs Research Topics

Disease

17Infections
11/2023 - 03/2011
16Fibrosis (Cirrhosis)
12/2022 - 05/2009
11Chronic Hepatitis C
04/2024 - 02/2011
5Hepatitis C
04/2022 - 05/2009
2Virus Diseases (Viral Diseases)
04/2024 - 01/2020
2Liver Diseases (Liver Disease)
12/2022 - 01/2021
2Portal Hypertension
04/2022 - 06/2011
2Anemia
01/2017 - 03/2011
1Intraabdominal Infections
11/2023
1Healthcare-Associated Pneumonia
11/2023
1Pyelonephritis
11/2023
1Urinary Tract Infections (Urinary Tract Infection)
11/2023
1Ventilator-Associated Pneumonia
11/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1Nasopharyngitis
01/2017
1Dysgeusia (Parageusia)
05/2014
1Hepatitis
07/2013
1Hepatocellular Carcinoma (Hepatoma)
06/2011
1Varicose Veins (Varicose Vein)
06/2011
1Disease Progression
06/2011
1Persistent Infection
03/2011

Drug/Important Bio-Agent (IBA)

15glecaprevir and pibrentasvirIBA
04/2024 - 01/2018
10Ribavirin (Virazole)FDA LinkGeneric
01/2020 - 05/2009
6Antiviral Agents (Antivirals)IBA
12/2022 - 07/2013
6peginterferon alfa-2b (Pegintron)FDA Link
05/2014 - 05/2009
5N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
05/2014 - 03/2011
4Protease Inhibitors (Protease Inhibitor)IBA
12/2022 - 07/2013
4InterferonsIBA
01/2020 - 06/2011
4P-300IBA
08/2019 - 01/2018
4paritaprevirIBA
04/2018 - 10/2015
4ombitasvirIBA
04/2018 - 10/2015
3glecaprevirIBA
01/2020 - 01/2018
3pibrentasvirIBA
01/2020 - 01/2018
3Ritonavir (Norvir)FDA Link
04/2018 - 10/2015
3Interferon-alpha (Interferon Alfa)IBA
06/2011 - 05/2009
2Proteins (Proteins, Gene)FDA Link
01/2018 - 07/2013
2RNA (Ribonucleic Acid)IBA
10/2015 - 05/2009
1carbapenemaseIBA
11/2023
1Serine (L-Serine)FDA Link
11/2023
1ceftazidime drug combination avibactamIBA
11/2023
1TabletsIBA
01/2020
1BilirubinIBA
01/2017
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
09/2013
1Peptide Hydrolases (Proteases)FDA Link
07/2013
1ErythropoietinFDA Link
03/2011

Therapy/Procedure

7Therapeutics
04/2022 - 05/2009
2Retreatment
03/2013 - 03/2011
1Duration of Therapy
01/2018